Contract facts
UnrestrictedNo full NAICS 811210 intel page yet. Browse NAICS intelligence
Biomerieux Vitek Analyzers Lease and Service Maintenance is a federal Unrestricted award for Defense Health Agency Hcd West held by Medpharm. Estimated value $145K ($75K obligated). Current period of performance ends Sep 30, 2026 (potential Sep 30, 2027). Last award drew 1 bidder. Place of performance: AGANA HEIGHTS GU. Related solicitation HT941024N0161.
Biomerieux vitek analyzers lease and service maintenance. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Sep 30, 2026 (17 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on HT941024P0280? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordMedpharm — $2.7M obligated across 15 awards (firm-wide, all agencies).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT941024P0280?
HT941024P0280 (Biomerieux vitek analyzers lease and service) is a Defense Health Agency Hcd West award with a potential value of $145K, currently held by Medpharm. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9410-24-P-0280?
HT9410-24-P-0280 is the dashed form of PIID HT941024P0280 (Biomerieux vitek analyzers lease and service), held by Medpharm. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT941024P0280?
Defense Health Agency Hcd West awarded HT941024P0280 to Medpharm (potential $145K).
Who is the incumbent on HT941024P0280?
Medpharm is the incumbent with $2.7M across 15 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Medpharm’s HT941024P0280 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT941024P0280? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.